Contracepção hormonal e sistema cardiovascular
Open accessThe DOI matches its Crossref record; 76 of the 78 references it cites were found in a registry or an index.
Abstract
Hormonal contraception is the most widely used method to prevent unplanned pregnancies. The literature has shown an association between cardiovascular risk and use of hormone therapy. With the purpose of providing better guidelines on contraception methods for women with risk factors for cardiovascular disease, we have reviewed the literature on the subject. This review describes the latest data from the scientific literature concerning the influence of hormonal contraceptives on arterial thrombosis, venous thrombosis and systemic high blood pressure, which are diseases that have become increasingly prevalent among young females.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition to increased risk of arterial and venous thrombosis, one of the most common consequences is increased blood pressure with an elevated risk for the development of hypertension.3”
From Oral contraceptive use, muscle sympathetic nerve activity, and systemic hemodynamics in young women (2015) · cites this paper as [3]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: The effects of implanon® on lipid metabolism in comparison with norplant®
Suherman, S. K., Affandi, B., & Korver, T. (1999) · Contraception · doi:10.1016/s0010-7824(99)00099-2 · Cited by 28
RetractedThe Practice Committee of the American Society for Reproductive Medicine
Birmingham, A. (2006) · Cited by 1,925
Medical-eligibility criteria for contraceptive use
Guillebaud, J. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04615-8 · Cited by 1,095
Canonico, M., Oger, E., Plu-Bureau, G., Conard, J., Meyer, G., Lévesque, H., Trillot, N., Barrellier, M.-T., Wahl, D., Emmerich, J., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.642280 · Cited by 864
Classification and pharmacology of progestins
Schindler, A. E., Campagnoli, C., Druckmann, R., Huber, J., Pasqualini, J. R., Schweppe, K. W., & Thijssen, J. H. H. (2003) · Maturitas · doi:10.1016/j.maturitas.2003.09.014 · Cited by 745
Rasmussen, B. (1995) · Cephalalgia · doi:10.1046/j.1468-2982.1995.1501045.x · Cited by 731
POMP, E. R., LENSELINK, A. M., ROSENDAAL, F. R., & DOGGEN, C. J. M. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.02921.x · Cited by 724
Center for Drug Evaluation and Research
National Cancer Institute (2020) · Definitions · doi:10.32388/doq9wu · Cited by 674
van Hylckama Vlieg, A., Helmerhorst, F. M., Vandenbroucke, J. P., Doggen, C. J. M., & Rosendaal, F. R. (2009) · BMJ · doi:10.1136/bmj.b2921 · Cited by 666
Medical eligibility criteria for contraceptive use
Trussell, J. (2011) · Human Fertility · doi:10.3109/14647273.2011.602520 · Cited by 482
Research works printed but not linked: 4
- [19]19. Odlind V, Milsom I, Persson I, Victor A. Can changes in sex hormone 31. binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills? Acta Obstet Gynecol Scand. 2002; 81 (6): 482-90.
- [20]20. Vieira CS, Oliveira LCO, Sá MFS. Hormônio femininos e hemostasia. Rev Bras Ginecol Obstet. 2007; 29 (10): 538-47.
- [27]27. Egberg N, van Beek A, Gunnervik C, Hulkko S, Hirvonen E, Larsson- Cohn U, et al. Effects on hemostatic system and liver function in relation to Implanonâ and Norplantâ: a prospective randomized clinical trial. Contraception. 1998; 58 (2): 93-8.
- [36]36. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Cardiovascular disease and use of oral and injectable progestogen only contraceptives. Contraception. 1998; 57 (5): 315-24.
Cited by
Factors associated with the contraindicated use of oral contraceptives in Brazil
Corrêa, D. A. S., Felisbino-Mendes, M. S., Mendes, M. S., Malta, D. C., & Velasquez-Melendez, G. (2017) · Revista de Saúde Pública · doi:10.1590/s1518-8787.2017051006113 · Cited by 212
Women-Specific Factors to Consider in Risk, Diagnosis and Treatment of Cardiovascular Disease
Harvey, R. E., Coffman, K. E., & Miller, V. M. (2015) · Women s Health · doi:10.2217/whe.14.64 · Cited by 146
Rathod, S., Shinde, K. S., Porlekar, J., Choudhari, P. B., Dhavale, R. P., Mahuli, D., Tamboli, Y., Bhatia, M. S., Haval, K. P., Al-Sehemi, A. G., et al. (2022) · ACS Omega · doi:10.1021/acsomega.2c04837 · Cited by 101
Oral contraceptive use, muscle sympathetic nerve activity, and systemic hemodynamics in young women
Harvey, R. E., Hart, E. C., Charkoudian, N., Curry, T. B., Carter, J. R., Fu, Q., Minson, C. T., Joyner, M. J., & Barnes, J. N. (2015) · HYPERTENSION · doi:10.1161/hypertensionaha.115.05179 · Cited by 76
“In addition to increased risk of arterial and venous thrombosis, one of the most common consequences is increased blood pressure with an elevated risk for the development of hypertension.(3) With long-term use of hormonal contraceptives, specifically combined oral contraceptives (OCs), systolic blood pressure has been…”
BackgroundSex, the brain and hypertension: brain oestrogen receptors and high blood pressure risk factors
Hay, M. (2015) · Clinical Science · doi:10.1042/cs20150654 · Cited by 79
Metadata
- Authors
- Brito, M. B., Nobre, F., & Vieira, C. S.
- Affiliations
- Universidade de São Paulo (BR)
- Venue
- Arquivos Brasileiros de Cardiologia
- Publisher
- FapUNIFESP (SciELO)
- Published
- 2011-04
- Volume
- 96
- Issue
- 4
- Pages
- e81-e89
- ISSN
- 0066-782X (ISSN-L)
- OpenAlex
- W1842948284
- Semantic Scholar
- fc04526a2751f6a52e424b77d270136ccb0d2c0a
- Cited by
- 78
- References
- 78
- Citations by year
- 2026: 1 · 2024: 5 · 2023: 5 · 2022: 23 · 2021: 14 · 2020: 4 · 2019: 2 · 2018: 1 · 2017: 6 · 2016: 5 · 2015: 5 · 2014: 5 · 2012: 2
- FWCI
- 2.19
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by-nc
- Locations
- Arquivos Brasileiros de Cardiologia (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (publishedVersion)
- Americanae (AECID Library) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- hormonal contraception, cardiovascular risk, arterial thrombosis, venous thrombosis, hypertension, cardiovascular risk factors, young women, contraceptive guidelines
- MeSH terms
- Contraindications, Cardiovascular Diseases, Cardiovascular System, Contraceptives, Oral, Hormonal, Female, Humans, Hypertension, Risk Factors, Thrombosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Contracepção hormonal e sistema cardiovascular. https://app.cochat.ai/papers/10.1590/s0066-782x2011005000022
- The paper
- Brito, M. B., Nobre, F., & Vieira, C. S. (2011). Contracepção hormonal e sistema cardiovascular. Arquivos Brasileiros de Cardiologia. https://doi.org/10.1590/s0066-782x2011005000022
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.